Moreover, we unveiled the clinical significance of the FOSL2/Wnt5a axis to gain insights into its pro-angiogenic function in the development and progression of breast carcinoma, suggesting potential novel therapeutic strategies for anti-angiogenic therapy. Here, FOSL2 is linked to breast carcinoma.